# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
-Reuters
Barclays analyst Matt Miksic maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Overweight and raises the price target from...
Wells Fargo analyst Larry Biegelsen maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Overweight and raises the price targ...
Piper Sandler analyst Matt O'Brien reiterates Tandem Diabetes Care (NASDAQ:TNDM) with a Overweight and raises the price ...
Stocks look set to carry forward the upward momentum on Friday amid some earnings cheer, although a tinge of nervousness is evi...